UNSPSC 51192014: Rasburicase

This classification denotes a uricosuric agent with the molecular formula C1521H2381N417O461S7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 08GY9K1EUO, more generally known as rasburicase. European Medicines Agency schedules rasburicase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04204MIG. The term RASBURICASE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 1, 2000, list 43. Most nations schedule Rasburicase under HS 35079090 and SITC 51691.

SMILES:. As of Q4 2014, RASBURICASE remains the US FDA Preferred Term for this commodity.. Rasburicase bears US NLM identifiers UMLS ID C0937932 and NCI Concept Code C2404.

UNSPSC 51192014 Rasburicase, a Commodity code, shows little relevant recent state and local procurement activity. The three opportunities posted under this code in the past six months—a District Attorney dog procurement from Washington County, Oregon; athletic training services from the City of Tucson; and medical aid supplies from the City of Tampa—bear no relationship to rasburicase, a urate oxidase medication used to treat hyperuricemia in oncology patients. The code appears to be misapplied in these instances, and no actual pharmaceutical procurement or rasburicase contracting activity is evident in recent state and local solicitations.

Without active rasburicase opportunities in the source record, the code does not present a current pursuit signal for vendors in pharmaceutical supply, specialty drugs, or oncology support services. State and local healthcare systems, hospital networks, and purchasing cooperatives would be the natural issuing bodies if rasburicase procurement were active, but the recent posting pattern does not support current demand tracking or pipeline development under this code.